language_icon
EN
HI

Valiant Laboratories Share price

VALIANTLAB

58

0.51 (-0.87%)
NSE
BSE
Last updated on 20 Feb, 2026 | 15:29 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

59.39

Today's Low

57.31

52 Week Low

56.53

52 Week High

115.19

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Valiant Laboratories Chart

Valiant Laboratories Share Key Metrics

Volume
13208.00
Market Cap
317.78 CR
LTQ@LTP
51@58.00
ATP
58.23
Var Margin
22.16 %
Circuit Range
46.81-70.21
Delivery %
74.69 %
Value
7.69 L
ASM/GSM
No
Market Lot
1

Summary

At 20 Feb, 2026 | 15:29, Valiant Laboratories share price stands at ₹58, showing a 0.51% -0.87 for the day. The stock’s intraday movement has stayed between ₹57.31 and ₹59.39, while on a 52-week basis it has fluctuated from ₹56.53 to ₹115.19.
In terms of trading activity, Valiant Laboratories has recorded a volume of 13208 shares, with a market capitalisation of ₹54312500. The stock’s Average Traded Price (ATP) stands at ₹5823, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 51,5800. The stock operates within a circuit range of ₹46.81-70.21, with a Value of ₹7.69 L. The Delivery Percentage for the day is 74.69%. Additionally, Valiant Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Valiant Laboratories Fundamentals

View More
P/E Ratio

0

P/B Ratio

1.03

Div. Yield

0

Sector P/E

63.23

Sector P/B

2.76

Sec. Div. Yield

0.57

Valiant Laboratories Resistance and Support

Pivot 58.94

Resistance

First Resistance

59.58

Second Resistance

60.64

Third Resistance

61.28

Support

First Support

57.88

Second Support

57.24

Third Support

56.18

Valiant Laboratories Futures & Options

Data Not Found

Valiant Laboratories Shareholding Pattern

View More
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

74.94%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.01%

Domestic Institutional Investors

0%

Retail

25.05%

Others

0%

Total Promoters
MAR '25
74.94%
JUN '25
74.94%
SEP '25
74.94%
DEC '25
74.94%

Valiant Laboratories Corporate Actions

DateAgenda
2026-02-11Quarterly Results
2025-11-11Quarterly Results
2025-08-08Quarterly Results
2025-07-09Others
2025-02-07Quarterly Results & Others

Valiant Laboratories News

Paracetamol API producer Valiant Laboratories lists shares at premium on NSE and BSE

Oct 06 2023 10:37:26

Paracetamol API producer Valiant Laboratories lists shares at premium on NSE and BSE

Oct 06 2023 10:37:18

Sun Pharma's acquisition, Valiant laboratories listing, BHEL and Lupin & more | Market Minutes

Oct 06 2023 08:52:19

Valiant Laboratories achieves strong IPO, eyes international expansion

Oct 06 2023 11:22:19
Read More

About Valiant Laboratories

NSE : 19218  
BSE : 543998  
ISIN : INE0JWS01017  

The Company was originally formed as a partnership firm under Indian Partnership Act 1932 under the name and style of “M/s Bharat Chemicals” pursuant to the deed of partnership dated October 17 1980. Subsequently the partnership firm M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name “Valiant Laboratories Limited” pursuant to certificate of incorporation dated August 16 2021 issued by Central Registration Centre Registrar of Companies. The corporate identity number of the Company is U24299MH2021PLC365904.Key events and milestones :1980- Formed M/s. Bharat Chemicals (a partnership firm)1981- Acquired plot No. L-30 in the Tarapur Industrial Area Palghar Maharashtra on leasehold basis admeasuring about 1000 sq. mtrs1982- Commenced manufacture of Paracetamol2004-05- Acquired additional Plot Nos. L-28 L-28 (part) L-29 and L-13 at Tarapur Industrial Area Palghar Maharashtra collectively admeasuring about 3000 sq.mtrs2015- The annual revenue from operations crossed Rs.500 million2021- Converted from partnership firm into a public limited company- The annual revenue from operations crossed Rs.1000 million2022- The annual revenue from operations crossed Rs.2000 million- Formed the wholly owned subsidiary VASPL to diversify the business activities

Read More

Valiant Laboratories Management

NamePosition
Mr. Santosh S Vora Managing Director
Mr. Paresh S Shah Executive Director & CFO
View More

Valiant Laboratories FAQs

The Buying Price of Valiant Laboratories share is 58 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Valiant Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Valiant Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Valiant Laboratories shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Valiant Laboratories shares is 1.03. Useful to assess the stock's value relative to its book value.

To assess Valiant Laboratories’s valuation compare Sector P/E, P/B which are 63.23 & 2.76 with sector averages, along with growth rates and financial metrics.

The Market Cap of Valiant Laboratories is 317.78 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Valiant Laboratories share price is 115.19 & 56.53. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Valiant Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost